Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
Metro, Giulio, Gariazzo, Eleonora, Costabile, Silvia, Baglivo, Sara, Roila, Fausto, Colamartini, Francesca, Palumbo, Barbara, Chiarini, Pietro, Gori, Stefania, Conti, Antonio, Marcomigni, Luca, Bellezza, Guido, Lunardi, Gianluigi
Published in Oncology and therapy (01.03.2024)
Published in Oncology and therapy (01.03.2024)
Get full text
Journal Article
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
Metro, Giulio, Gariazzo, Eleonora, Costabile, Silvia, Baglivo, Sara, Roila, Fausto, Colamartini, Francesca, Palumbo, Barbara, Chiarini, Pietro, Gori, Stefania, Conti, Antonio, Marcomigni, Luca, Bellezza, Guido, Lunardi, Gianluigi
Published in Oncology and therapy (01.03.2024)
Published in Oncology and therapy (01.03.2024)
Get full text
Journal Article
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
Favorito, Valentina, Ricciotti, Ilaria, De Giglio, Andrea, Fabbri, Laura, Seminerio, Renata, Di Federico, Alessandro, Gariazzo, Eleonora, Costabile, Silvia, Metro, Giulio
Published in Expert opinion on emerging drugs (01.06.2024)
Published in Expert opinion on emerging drugs (01.06.2024)
Get more information
Journal Article